(4-((4-(tert-Butoxycarbonyl)piperazin-1-yl)methyl)phenyl)boronic acid, 95.0%, 1g

4-hydrazinyl-2-(thiophen-2-yl)pyrimidine, 95.0%, 250mg

4'-Fluoro-2'-(trifluoromethyl)acetophenone, 98.0%, 5g

3,5-Di-tert-butylcatechol, 98.0%, 5g

2,2'-(1,2-Phenylene)diacetic acid, 95.0%, 1g

Ethyl 5-phenyl-1,3,4-oxadiazole-2-carboxylate, 95.0%, 2.5g

7-MAC, 95.0%, 1g

4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridin-2-ylamine, 95.0%, 100mg

tert-butyl (2S,5R)-5-(hydroxymethyl)-2-methylpiperidine-1-carboxylate, 95.0%, 250mg

N,N-Dimethyl-1,3-cyclohexanediamine (cis- and trans- mixture)>98.0%(GC)(T)1g

(1S,2R)-2-Phenylcyclopropanamine, 95.0%, 100mg

Recipiente de cristalización DURAN® sin pico, 900 ml, 140 mm, 1 Pieza

2,6-Dichloroaniline, 98.0%, 100g